Vanguard Group Inc Rocket Pharmaceuticals, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RCKT
# of Institutions
222Shares Held
98.4MCall Options Held
611KPut Options Held
474K-
Rtw Investments, LP New York, NY17.7MShares$57 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$26.9 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$19.9 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$15.5 Million0.17% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.14MShares$13.3 Million0.35% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $244M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...